1–10 of 99 results for Age-Related Macular Degeneration
Characteristics of Fellow Eye Conversion to Neovascular Age-Related Macular Degeneration in Patients With Unilateral Neovascular Disease
Matthew Starr, MD
Annual Meeting Talks
2020
Two-Year Real-World Treat and Extend Patterns and Fluid Outcomes Among Neovascular Age-Related Macular Degeneration Patients Treated With Anti-VEGFs
Michael A. Singer, MD
Fluctuations in Central Foveal Thickness and Vision Outcomes With Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration
Veeral S. Sheth, MD, MBA, FASRS, FACS
Nonneovascular Age Related Macular Degeneration and Fluid
David Sarraf, MD
Cognitive Testing in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Wet Age-Related Macular Degeneration
Subhransu K. Ray, MD, PhD
Combination of Dexamethasone Implant and Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration
Raja Narayanan, MD, MBA
Modifier-25 Examinations Reduce Travel Burden, Decrease Treatment Cost, and Improve QALY for Exudative Age-Related Macular Degeneration Patients
Henry A Leder, MD
Performance of a Novel Deep Learning Algorithm for Automatic Retinal Fluid Quantification in Home OCT Images
Judy E. Kim, MD, FASRS
Loss to Follow-up in Patients With Neovascular Age-Related Macular Degeneration Treated With Anti-VEGF Therapy in the United States
Rahul N. Khurana, MD, FASRS
RGX-314 for Neovascular AMD: Ongoing Phase I/IIa Results for Cohorts 1-5
Arshad M. Khanani, MD, MA, FASRS